tiprankstipranks
Trending News
More News >
Alpha Cognition Inc (ACOG)
NASDAQ:ACOG
US Market

Alpha Cognition Inc (ACOG) Earnings Dates, Call Summary & Reports

Compare
6 Followers

Earnings Data

Report Date
Jun 03, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
Last Year’s EPS
-0.03
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 31, 2025
|
% Change Since: -23.87%
|
Next Earnings Date:Jun 03, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a company in a strong position following a successful capital raise and the commercial launch of ZUNVEYL. Positive feedback from the market and a strong cash position are highlights, despite increased operating and net losses due to higher expenses. The company's strategic initiatives and partnerships suggest a positive outlook.
Company Guidance
During the earnings call, Alpha Cognition provided guidance related to their financial and operational outlook. The company did not provide specific revenue guidance for 2025 but projected operating expenses to range between $38 million and $42 million for the year. The recent successful capital raise of $52 million and a strong cash position of $48.6 million as of December 31, 2024, are expected to support the company until it reaches cash flow breakeven status by year three of ZUNVEYL's launch. This financial target assumes successful execution of their commercial strategy and disciplined expense management. The company also highlighted their strategic priorities, including driving market penetration, expanding payer coverage, and maintaining focus on financial discipline and operational execution.
Successful Capital Raise and NASDAQ Listing
Alpha Cognition successfully raised $52 million in gross proceeds and executed a cross-list from the Canadian Securities Exchange to NASDAQ. This capital is expected to be sufficient for the company to reach breakeven status by year three of launch.
Commercial Launch of ZUNVEYL
Launch of ZUNVEYL for mild to moderate Alzheimer's disease in the US long-term care market. Initial positive feedback from prescribers and proactive interest from customers indicate strong initial demand.
Strong Cash Position
As of December 31, 2024, the company had approximately $48.6 million in cash, a substantial increase from $1.4 million at the end of 2023, attributed to a successful capital raise.
Expansion of Intellectual Property Portfolio
Secured a new composition of matter patent in the US, extending ZUNVEYL protection through 2044, with additional territories under review.
Promising Pipeline Developments
Reclaimed two programs from Alpha Seven Therapeutics and initiated work on a sublingual formulation of ALPHA-1062 for Alzheimer's patients with dysphasia or aphasia.
Partnership with CMS Pharmaceuticals
Made significant progress with CMS Pharmaceuticals for representing ZUNVEYL R&D and distribution in China and greater Asian territories.
---

Alpha Cognition Inc (ACOG) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ACOG Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jun 03, 20252025 (Q1)
- / -
-0.03
Mar 31, 20252024 (Q4)
-0.58 / -0.51
-0.7532.00% (+0.24)
Nov 15, 20242024 (Q3)
-1.00 / -0.31
-0.7558.67% (+0.44)
Aug 12, 20242024 (Q2)
-1.00 / -0.25
-0.7566.67% (+0.50)
May 14, 20242024 (Q1)
- / -
-0.02
Apr 03, 20242023 (Q4)
- / -0.75
-0.5-50.00% (-0.25)
Nov 28, 20232023 (Q3)
- / -0.75
-125.00% (+0.25)
Aug 22, 20232023 (Q2)
- / -0.75
-1.2540.00% (+0.50)
May 30, 20232023 (Q1)
- / -0.50
-150.00% (+0.50)
Mar 08, 20232022 (Q4)
- / -1.25
-1.7528.57% (+0.50)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

ACOG Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 31, 2025$5.53$5.06-8.50%
Nov 15, 2024$5.68$5.37-5.46%
Aug 12, 2024$11.50$12.29+6.87%
May 14, 2024$12.51$12.75+1.92%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Alpha Cognition Inc (ACOG) report earnings?
Alpha Cognition Inc (ACOG) is schdueled to report earning on Jun 03, 2025, TBA Not Confirmed.
    What is Alpha Cognition Inc (ACOG) earnings time?
    Alpha Cognition Inc (ACOG) earnings time is at Jun 03, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ACOG EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis